DFM Platform
DFM Funding Monitor

AcceleRating the Translation of virtual twins towards a pErsonalised Management of fatty lIver patientscore

ARTEMIS · Horizon Europe grant · 2024-01-01–2027-12-31

EC contribution

€9,365,095

Total cost

€9,365,096

Beneficiaries

21
About the data

Source: CORDIS (official EU open data), Horizon Europe. Framework HORIZON · call HORIZON-HLTH-2023-TOOL-05 · scheme HORIZON-RIA · topic HORIZON-HLTH-2023-TOOL-05-03. CORDIS record →

Objective

The ARTEMIs project aims to consolidate existing computational mechanistic and machine-learning models at different scales to deliver ‘virtual twins’ embedded in a clinical decision support system (CDSS). The CDSS will provide clinically meaningful information to clinicians, for a more personalised management of the whole spectrum of Metabolic Associated Fatty Liver Disease (MAFLD). MAFLD, with an estimated prevalence of about 25%, goes from an undetected sleeping disease, to inflammation (hepatitis), to fibrosis development (cirrhosis) and/or hepatocellular carcinoma (HCC), decompensated cirrhosis and HCC being the final stages of the disease. However, many MAFLD patients do not die from the liver disease itself, but from cardiovascular comorbidities or complications.The ARTEMIs will contribute to the earlier management of MAFLD patients, by prognosing the development of more advanced forms of the disease and cardiovascular comorbidities, promoting active surveillance of patients at risk. The system will predict the impact of novel drug treatments or procedures, or simply better life habits. The system will therefore not only serve as a clinical decision aid tool, but also as an educational tool for patients, to promote better nutritional and lifestyle behaviors.In more advanced forms of the disease, therapeutic interventions include TIPPS to manage portal hypertension, partial hepatectomy, partial or complete liver transplant. ARTEMIs will contribute to predict per- or post-intervention heart failure, building on existing microcirculation hemodynamics models.The model developers will benefit from a large distributed patient cohort and data exploration environment to identify patterns in data, draw new theories on the liver-heart metabolic axis and validate the performance of their models. The project includes a proof-of-concept feasibility study assessing the utility of the integrated virtual twins and CDSS in the clinical context.

Beneficiaries (21)

OrganisationCountryRoleEC contributionSME
MATICAL INNOVATION SL ES coordinator €477,125 Yes
INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET AUTOMATIQUE FR participant €1,216,250
BC PLATFORMS FR participant €936,500 Yes
DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG DE participant €920,586
UNIVERSITAET LEIPZIG DE participant €766,595
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA ES participant €724,000
UNIVERSITATSKLINIKUM JENA DE participant €678,505
ALBERT-LUDWIGS-UNIVERSITAET FREIBURG DE participant €501,000
FONDATION CARDIOMETABOLISME NUTRITION FR participant €475,000
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS FR participant €424,937
UNIVERSITATSKLINIKUM HEIDELBERG DE participant €395,250
MEDIZINISCHE UNIVERSITAET WIEN AT participant €353,750
FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA ES participant €300,875
CHARITE - UNIVERSITAETSMEDIZIN BERLIN DE participant €296,500
CLINIQUES UNIVERSITAIRES SAINT-LUC ASBL BE participant €296,500
EUROPEAN LIVER PATIENTS ASSOCIATION BE participant €199,000
BETTHERA SRO CZ participant €185,000 Yes
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA IT participant €151,722
MEDICAL RESEARCH INFRASTRUCTURE DEVELOPMENT AND HEALTH SERVICES FUND BY THE SHEBA MEDICAL CENTER IL participant €66,000
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE UK associatedPartner
BOURNEMOUTH UNIVERSITY UK associatedPartner

Get the DFM funding briefing — free

New EU defence calls, tenders and awards in your inbox.

Countries
Sectors
Sources

We store your email only to send the DFM briefing/alerts and to add you to DFM Analysis. Unsubscribe anytime.

Defence Finance Monitor is an analytical and informational product. Grant data is official CORDIS; payment and subscription happen on DFM Analysis.